Mechanisms of action of glucocorticoids in asthma;Les mecanismes d'action moleculaire des glucocorticoides dans l'asthme

Revue des Maladies Respiratoires

Volumn 16, Issue 4, 1999, Pages 431-442

  Jaffuel, D ^a   Mathieu, M ^a   Godard, Ph ^a   Michel, F B ^a   Demoly, P ^a  

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

AP 1; Cytokines; Glucocorticoids; GRE; NF B

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; EOTAXIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LIPOCORTIN; MESSENGER RNA; METALLOPROTEINASE; RANTES; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; GENETIC TRANSCRIPTION; PROMOTER REGION; PROTEIN BINDING; REVIEW; TRANSACTIVATION; TRANSCRIPTION REGULATION; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; PHYSIOLOGY;

ASTHMA; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; PROMOTER REGIONS (GENETICS); RECEPTORS, GLUCOCORTICOID; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0033193993     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (122)

1. HENCH P, KENDALL E, SLOCUMB C, POLLEY H : The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Staff Meet Mayo Clinic 1949;24:181-97.
2. RANDOLPH T, ROLLINS J : Effect of cortisone in bronchial asthma. J Allergy Clin Immunol 1950;21:228-95.
3. NOONAN M, CHERVINSKY P, BUSSE W : Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med 1995;152:1467-73.
4. LACRONIQUE J, RENON D, GEORGES D, HENRY-AMAR M, MARSAC J : High-dose beclomethasone: oral steroid-sparing effect in severe asthmatic patients. Eur Respir J 1991;4:807-12.
5. SALMERON S, GUERIN J, GODARD Ph et al. : Hight dose of inhaled corticosteroids in unstable asthma. Am Rev Respir Dis 1989;140:167-71.
6. LAITINEN L, LAITINEN L, HAAHTELA T : Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:697-704.
7. ESSEN-ZANDVLIET EV, HUGHES M, WAALKENS H et al. : Effects of 22 months of treatment with inhaled corticosteroids and/or β-2-agonist on lung function, airway responsiveness, and symptoms in children with asthma. Am Rev Respir Dis 1992;146:547-54.
8. HAAHTELA T, JARVINEN M, KAVA T et al. : Comparison of a β2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-92.
9. LAITINEN L, LAITINEN L, HAAHTELA T et al. : A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double bind, parallel-group controlled trial. J Allergy Clin Immunol 1992;90:32-42.
10. HAAHTELA T, JARVINEN M, KAVA T et al. : Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
11. SELROOS O, PIETINALHO A, LOFROOS A, RISKA H : Effect of early versus late intervention with inhaled corticosteroid in asthma. Chest 1995;108:1228-34.
12. NATIONAL HEART LUNG AND BLOOD INSTITUTE/NATIONAL ASTHMA EDUCATION PROGRAM/EXPERT PANEL REPORT : Guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 1991;88:425-534.
13. GLOBAL INITIATIVE FOR ASTHMA NATIONAL HEART LUNG AND BLOOD INSTITUTE : Global strategy for asthma management and prevention. Publication Number 97-4051.
14. BRITISH THORACIC SOCIETY : Guidelines for management of asthma in adults: I- chronic persistent asthma. BMJ 1990;301:651-3.
15. BEATO M : Gene regulation by steroid hormones. Cell 1989;56:335-44.
16. MULLER M, RENKAWITZ R : The glucocorticoid receptor. Biochim Biophys Acta 1991;1088:171-82.
17. PRATT W : The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J Biol Chem 1993;268:21455-8.
18. HOWARD K, DISTELHORST C : Evidence for intracellular association of the glucocorticoid receptor with the 90-kDa heat shock protein. J Biol Chem 1989;263:3474-81.
19. MARTINS V, PRATT W, TERRACIO L et al. : Demonstration by confocal microscopy that unliganded overexpressed glucocorticoid receptors are distributed in a nonrandom manner throughout all planes of the nucleus. Mol Endocrinol 1991;5:217-225.
20. SANCHEZ E, HIRST M, SCHERRER L et al. : Hormone-free mouse glucocorticoid receptors overexpressed in Chinese hamster ovary cells are localized to the nucleus and are associated with both hsp70 and hsp90. J Biol Chem 1990;265:20123-30.
21. GASC J, DELAHAYE F, BAULIEU E : Compared intracellular localization of the glucocorticosteroid and progesterone receptors: an immunocytochemical study. Exp Cell Res 1989;181:492-504.
22. MATHIEU M, JAFFUEL D, GOUGAT C et al. : Modulation of AP-1 activity by the unliganded glucocorticoid receptor. FEBS 1997; Special Meeting 97.
23. LIU W, HILLMANN A, HARMON J : Hormone-independent repression of AP-1-inducible collagenase promoter activity by glucocorticoid receptors. Mol Cell Biol 1995;15:1005-13.
24. JONAT C, RAHMSDORF HJ, PARK KK et al. : Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990;62:1189-204.
25. HECK S, KULLMANN M, GAST A et al. : A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 1994;13:4087-95.
26. VIGNOLA A, CHANEZ P, POLLA B et al. : Increased expression of heat shock protein 70 on airway cells in asthma and chronic bronchitis. Am J Respir Cell Mol Biol 1995;13:683-91.
27. FAJAC I, ROISMAN G, LACRONIQUE J et al. : Bronchial T-lymphocytes and expression of heat shock proteins in mild asthma. Eur Respir J 1997;10:633-8.
28. HOLLENBERG S, WEINBERGER C, ONG E et al. : Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 1985;318:635-41.
29. OAKLEY R, SAR M, CIDLOWSKI J : The human glucocorticoid receptor β isoform. Expression, biochemical properties and putative function. J Biol Chem 1996;271:9550-9.
30. BAMBERGER C, BAMBERGER A, CASTRO MD, CHROUSOS G : Glucocorticoid receptor b, a potential endogenous inhibitor of glucocorticoid actions in humans. J Clin Invest 1995;95:2435-41.
31. HECHT K, DUKE J, STIERNA P et al : Evidence that the β-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem 1997;272:26659-64.
32. LEUNG D, HAMID Q, VOTTERO A et al. : Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J Exp Med 1997;186:1567-74.
33. OAKLEY R, WEBSTER J, SAR M, PARKER C, CIDLOWSKI J : Expression and subcellular distribution of the β-isoform of the human glucocorticoid receptor. Endocrinology 1997;138:5028-38.
34. ADCOCK IM, GILBEY T, GELDER C, CHUNG K, BARNES PJ : Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med 1996;154:771-82.
35. KORN S, WOUTERS E, WESSELING G, ARENDS J, THUNNISSEN F : In vitro and in vivo modulation of α- and β-glucocorticoid-receptor mRNA in human bronchial epithelium. Am J Respir Crit Care Med 1997;155:1117-22.
36. SILVA C, POWELL-OLIVER F, JEWELL C et al. : Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 1994;59:436-42.
37. BELLINGHAM D, SAR M, CIDLOWSKI J : Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness. Mol Endocrinol 1992;6:2090-102.
38. OKRET S, DONG Y, BRÖNNEGARD M, GUSTAFSSON J : Regulation of glucocorticoid receptor expression. Biochemistry 1991;73:51-9.
39. LECLERC S, PALANISWAMI R, XIE B, GOVIDAN M : Molecular cloning and characterization of a factor that binds the human glucocorticoid receptor gene and represses its expression. J Biol Chem 1991;266:17333-40.
40. BRÖNNEGARD M : Steroid receptor number. Individual variation and down-regulation by treatment. Am J Respir Crit Care Med 1996;154:S28-S33.
41. VACHIER I, Roux I, CHANEZ P et al. : Glucocorticoids induced down-regulation of glucocorticoid receptor mRNA expression in asthma. Clin Exp Immunol 1996;103:311-5.
42. AKERBLOM I, SLATER E, BEATO M, BAXTER J, MELLON P : Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer. Science 1988;241:350-60.
43. MEYER T, CARLSTEDT-DUKE J, STARR D : A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene. J Biol Chem 1997;272:30709-14.
44. DELANAY A, CANALIS E : Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells. Endocrinology 1995;136:4776-81.
45. DROUIN J, CHARRON J, GAGNER J : The pro-pionomelanocortin gene: a model for negative regulation of transcription by glucocorticoids. J Cell Biochem 1987;35:293-304.
46. MURPHY E, CONNEELY O : Neuroendocrine regulation of the hypothalamic pituitary adrenal axis by the nurr1/nur77 subfamily of nuclear receptors. Mol Endocrinol 1997;11:39-47.
47. OKABE T, TAKAYANAGI R, ADACHI M, IMASAKI K, NAWATA H : Nur77, a member of the steroid receptor superfamily, antagonizes negative feedback of ACTH synthesis and secretion by glucocorticoid in pituitary corticotrope cells. J Endocrinol 1998;156:169-75.
48. PHILIPS A, MAIRA M, MULLICK A et al. : Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol Cell Biol 1997;17:5952-9.
49. POMPEO A, LUINI A, HIRATA F, BALDASSARRE M, BUCCIONE R : Neutrophil extracted lipocortin inhibits corticotropin secretion in the AtT-20 D16 clonal mouse pituitary cell line. Lipocortin inhibition of ACTH release in vitro. Regul Pept 1991;31:169-77.
50. TAYLOR A, CHRISTIAN H, MORRIS J, FLOWER R, BUCKINGHAM J : An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotropin from rat pituitary tissue in vitro. Endocrinology 1997;138:2909-18.
51. TAYLOR A, FLOWER R, BUCKINGHAM J : Dexamethasone inhibits the release of TSH from the rat anterior pituitary gland in vitro by mechanism dependent on de novo protein synthesis and lipocortin 1. J Endocrinol 1995;147:533-44.
52. MING M, CHAN W, WANG T et al. : Beta-adrenoceptors and dexamethasone synergistically stimulate the expression of the angiotensinogen gene in opossum kidney cells. Kidney Int 1996;50:94-101.
53. Guo D, UNO S, INAGAMI T : Steroid hormones upregulate rat angiotensin II type 1A receptor gene: role of glucocorticoid responsive elements in rat angiotensin II type 1A promoter. J Steroid Biochem Mol Biol 1995;53:69-73.
54. GUO D, UNO S, ISHIHATA A, NAKAMURA N, INAGAMI T : Identification of a cis-acting glucocorticoid responsive element in the rat angiotensin II type 1A promoter. Circ Res 1995;77:249-57.
55. EMORINE L, MARULLO S, DELAVIER-KLUTCHKO C et al. : Structure of the gene for human β2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci USA 1987;84:6995-9.
56. JANTZEN H, STRAHLE U, GLOSS B et al. : Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 1987;49:29-38.
57. IMAI E, MINER J, MITCHELL J, YAMAMOTO K, GRANNER D : Glucocorticoid receptor-cAMP response element binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 1993;268:5353-6.
58. NGUYEN T, CHEN P, HUANG W et al. : Gene structure and properties of TIGR, an olfactomedin-related glycoprotein cloned from glucocorticoid-induced trabecular meshwork cells. J Biol Chem 1998;273:6341-50.
59. AUPHAN N, DIDONATO J, ROSETTE C, HELMBERG A, KARIN M : Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 1995;270:286-90.
60. SCHEINMAN R, COGSWELL P, LOFQUIST A, BALDWIN AJ : Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 1995;270:283-6.
61. MAK J, NISHIKAWA M, SHIRASAKI H, MIYAYASU K, BARNES P : Protective effects of a glucocorticoid on downregulation of pulmonary β2-adrenergic receptors in vivo. J Clin Invest 1995;96:99-106.
62. SUDLOW A, CAREY F, FORDER R, ROTHWELL N : The role of lipocortin-1 in dexamethasone-induced suppression of PGE2 and TNF alpha release from human peripheral blood mononuclear cells. Br J Pharmacol 1996;117:1449-56.
63. IMAI Y, KOHSAKA S : Structure of rat annexin V gene and molecular diversity of its transcripts. Eur J Biochem 1995;232:327-34.
64. ADCOCK IM : Transcription factors as activators of gene transcription: AP-1 and NF-κB. Monaldi Arch Chest Dis 1997;52:178-86.
65. ANGEL P, KARIN M : The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-57.
66. BARNES PJ, ADCOCK IM : Transcription factors and asthma. Eur Respir J 1998;12:221-34.
67. CATO A, WADE E : Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 1996;18:371-8.
68. DEMOLY P, MATHIEU M, JAFFUEL D et al. : Effects of C-FOS, C-JUN, FRA-1 and the glucocorticoid receptor on AP-1 activity: a cellular model of cortico-resistance. J Allergy Clin Immunol 1997;99, Part2:A2011.
69. KERPPOLA TK, LUK D, CURRAN T : Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol Cell Biol 1993;13:3782-91.
70. KAMEI Y, XU L, HEINZEL T et al. : A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 1996;85:403-14.
71. KÖNIG H, PONTA H, RAHMSDORF HJ, HERRLICH P : Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 1992;11:2241-6.
72. YANG-YEN HF, CHAMBARD J-C, SUN Y et al. : Transcriptional interference between c-jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990;62:1205-15.
73. ADCOCK IM, LANE SJ, BROWN CR, LEE TH, BARNES PJ : Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma. J Exp Med 1995;182:1951-8.
74. ADCOCK IM : Steroid resistance in asthma. Molecular mechanisms. Am J Respir Crit Care Med 1996;154:S58-S61.
75. ADCOCK IM, LANE SJ, BROWN CR et al. : Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 1995;154:3500-5.
76. SCHÜLE R, RANGARAJAN P, KLIEWER S et al. : Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 1990;62:1217-26.
77. STOCKLIN E, WISSLER M, GOUILLEUX F, GRONER B : Functional interaction between Stat5 and the glucocorticoid receptor. Nature 1996;383:726-8.
78. MORDACQ J, LINZER D : Co-localization of elements required for phorbol ester stimulation and glucocorticoid repression of proliferin gene expression. Gen & Develop 1989;3:760-9.
79. DIAMOND MI, MINER JN, YOSHINAGA SK, YAMAMOTO KR : Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990;249:1266-72.
80. BAEUERLE P, BALTIMORE D : I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 1988;242:540-6.
81. BAEUERLE P, BALTIMORE D : A 65-kD subunit of active NF-kB is required for inhibition of NF-kB by IkB. Genes Dev 1989;3:1689-98.
82. BARNES P, KARIN M : Nuclear factor-kB. A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
83. SIEBENLIST U, FRANZOSO G, BROWN K : Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994;10:405-55.
84. SCHEINMAN RI, GUALBERTO A, JEWELL CM, CIDLOWSKI JA, BALDWIN J : Characterization of mechanisms involved in transrepression of NF-kB by activated glucocorticoid receptors. Mol Cell Biol 1995;15:943-53.
85. RAY A, PREFONTAINE K : Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 1994;91:752-6.
86. HECK S, BENDER K, KULLMANN M et al. : I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J 1997;16:4698-707.
87. BROSTJAN C, ANRATHER J, SIZMADIA V et al. : Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaB alpha synthesis. J Biol Chem 1996;271:19612-6.
88. WISSINK S, HEERDE EV, VAN SAAG P : A dual mechanism mediates repression of NF-kB activity by glucocorticoids. Mol Endocrinol 1998;12:355-63.
89. LIDEN J, DELAUNAY F, RAFTER I, GUSTAFSSON J, OKRET S : A new function for the C-terminal zinc finger of the glucocorticoid receptor. Repression of RelA transactivation. J Biol Chem 1997;272:21467-72.
90. GERRITSEN M, WILLIAMS A, NEISH A et al. : CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci USA 1997;94:2927-32.
91. PAEK I, AXEL R : Glucocorticoids enhance stability of human growth hormone mRNA. Mol Cell Biol 1987;7:1496-505.
92. PEPPEL K, VINCI J, BAGLIONI C : The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J Exp Med 1991;173:349-55.
93. SHAW G, KAMEN R : A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986;46:659-67.
94. MALTER J : Identification of an AUUUA-specific messenger RNA binding protein. Science 1989;246:664-9.
95. PALIOGIANNI F, RAPTIS A, AHUJA S, NAJJAR S, BOUMPAS D : Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. J Clin Invest 1993;91:1481-9.
96. MASQUILLIER D, SASSONE-CORSI P : Transcriptional cross-talk: nuclear factor CREM and CREB bind to AP-1 sites and inhibit activation by jun. J Biol Chem 1992;267:22460-6.
97. STEIN B, BALDWIN A, BALLARD D et al. : Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 1993;12:3879-91.
98. JAFFUEL D, MATHIEU M, TARODO P et al. : Corticothérapie et inflammation bronchique : apport des biopsies bronchiques. Rev Mal Respir 1998;15:225-38.
99. SHIH W, MEARS T, BRADLEY D, PARADOOSH Z, WEINBERGER C : An adenoviral vector system for functional identification of nuclear receptor ligands. Mol Endocrinol 1991;5:300-9.
100. VAYSSIERE B, DUPONT S, CHOQUART A et al. : Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol 1997;11:1245-55.
101. HISCOTT J, MAROIS J, GAROUFALIS J : Characterization of a functional NF-kB site in the human interleukin beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 1993;13:6231-40.
102. LEE S, TSOU A, CHAN H : Glucocorticoids selectively inhibit the transcription of the interleukin 1β gene and decrease the stability of interleukin 1β mRNA. Proc Natl Acad Sci USA 1988;85:1204-9.
103. RE F, MUZIO M, ROSSI MD : The type II «receptor» as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor. J Exp Med 1994;179:739-43.
104. LAMAS M, CAMPOS J, SILVA A : Identification of a novel glucocorticoid response unit (GRU) in the 5′-flanking region of the mouse IL-2 receptor alpha gene. Cytokine 1997;12:973-81.
105. LAMAS M, SANZ E, MARTIN-PARRAS L et al. : Glucocorticoid hormones upregulate interleukin 2 receptor alpha gene expression. Cell Immunol 1993;151:437-50.
106. TANABE T, KONISHI M, MIZUTA T, NOMA T, HONJO T : Molecular cloning and structure of the human interleukin-5 gene. J Biol Chem 1987;262:16580-4.
107. KICK G, MESSER G, GOETZ A, PLEWIG G, KIND P : Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kappa B DNA binding. Cancer Res 1995;55:2373-9.
108. LIBERMANN T, BALTIMORE D : Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol 1990;10:2327-34.
109. RAY A, LAFORGE K, SEHGAL P : On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion. Mol Cell Biol 1990;10:5736-46.
110. MUKAIDA N, MORITA M, ISHIKAWA Y et al. : Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 1994;269:13289-95.
111. MCKENZIE A, LI X, LARGAEPADA D et al. : Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 1993;150:5436-44.
112. HEIN H, SCHLÜTER C, KULKE R et al. : Genomic organization, sequence, and transcriptional regulation of the human eotaxin gene. Biochem Biophys Res Commun 1997;237:537-42.
113. NELSON P, KIM H, MANNING W, GORALSKI T, KRENSKY A : Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 1993;151:2601-2612.
114. KLEINERT H, EUCHENHOFER C, IHRIG-BIEDERT I, FÖRSTERMANN U : Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokin-induced activity of transcription factor nuclear factor-κB. Mol Pharmacol 1996;49:15-21.
115. ANDERSSON S, ZACKRISSON C, HEMSEN A, LUNDBERG J : Regulation of lung endothelin content by the glucocorticosteroid budesonide. Biochem Biophys Res Comm 1992;188:1116-21.
116. RAGHOW R, GOSSAGE D, KANG A : Pretranslational regulation of type I collagen, fibronectin protein by dexamethasone in rats fibroblats. J Biol Chem 1986;261:4677-83.
117. ARYA S, WONG-STAAL F, GALLO R : Dexamethasone-mediated inhibition of human T cell growth factor and interferon messenger RNA. J Immunol 1984;133:273-9.
118. FRISH S, RULEY H : Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 1987;262:16300-4.
119. AHO S, ROUDA S, KENNEDY S, QIN H, TAN E : Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor. Eur J Biochem 1997;247:503-10.
120. KASZUBSKA W, HUIJSDUIJNEN RV, GHERSA P : Cyclic AMP-independant ATF family members interact with NF-κB and function in the activation of the E-selectin promoter in response to cytokines. Mol Cell Biol 1993;13:7180-90.
121. NEISH A, WILLIAMS A, PALMER H, WHITLEY M, COLLINS T : Functional analysis of the human vascular cell adhesion molecule 1 promoter. J Exp Med 1992;176:1583-93.
122. STOLPE P, CALDENHOVEN E, STADE B : 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor a-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. J Biol Chem 1994;269:6185-92.